Mechanistically, SA-Pa treatment promoted M2 macrophage activation that enhanced the anti-inflammatory function in the liver, downregulated STAT3 target genes, as well as alleviated apoptosis and necroptosis caused by the ALI. The gene discussed is STAT3; the disease is acute respiratory distress syndrome.